⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 16, 2018Expert Review of Respiratory MedicineOpen Access

Dual LABA/LAMA bronchodilators in chronic obstructive pulmonary disease: why, when, and how

Luigino Calzetta Maria Gabriella Matera Paola Rogliani Mario Cazzola

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Dual bronchodilation therapy is the cornerstone for the treatment of chronic obstructive pulmonary disease (COPD) [1]. Combining a long-acting β2 adrenoceptor (β2-AR) agonist (LABA) with a long-act...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Calzetta et al. (2018) studied this question.

synapsesocial.com/papers/6a7aef12e357fbdac589b5d7 https://doi.org/10.1080/17476348.2018.1442216

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1LABA/LAMA combination in COPD: a meta-analysis on the duration of treatmentNetwork Meta-Analysis · 2017 · 72 citations
2Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchiIn Vitro Study · 2014 · 91 citations
3Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cellsIn Vitro Study · 2016 · 101 citations
4Translational Study Searching for Synergy between Glycopyrronium and IndacaterolClinical Trial · 2014 · 85 citations
5Magnitude of umeclidinium/vilanterol lung function effect depends on monotherapy responses: Results from two randomised controlled trialsRCT · 2016 · 64 citations

Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study2017
Assessing the clinical value of fast onset and sustained duration of action of long-acting bronchodilators for COPD2015
β2-Agonist Therapy in Lung Disease2013
Navigating complexity: current evidence and recommendations for management of selected, non-malignant pleural effusionsExpert Review of Respiratory Medicine · 2026
Heat and childhood respiratory health: exploring the evidence and raising the red flagsExpert Review of Respiratory Medicine · 2026

More from Expert Review of Respiratory Medicine

More from University of Rome Tor Vergata

More from University of Campania "Luigi Vanvitelli"